CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
Straus, David J., Jung, Sin-Ho, Pitcher, Brandelyn, Kostakoglu, Lale, Grecula, John C., Hsi, Eric D., Schöder, Heiko, Popplewell, Leslie L., Chang, Julie E., Moskowitz, Craig H., Wagner-Johnston, Nina, Leonard, John P., Friedberg, Jonathan W., Kahl, Brad S., Cheson, Bruce D., Bartlett, Nancy L.
Published in Blood (06.09.2018)
Published in Blood (06.09.2018)
Get full text
Journal Article
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma
Kambhampati, Swetha, Saumoy, Monica, Schneider, Yecheskel, Serrao, Steve, Solaimani, Pejman, Budde, Lihua Elizabeth, Mei, Matthew G., Popplewell, Leslie L., Siddiqi, Tanya, Zain, Jasmine, Forman, Stephen J., Kwak, Larry W., Rosen, Steven T., Danilov, Alexey V., Herrera, Alex F., Thiruvengadam, Nikhil R.
Published in Blood (10.11.2022)
Published in Blood (10.11.2022)
Get full text
Journal Article
Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma
Godfrey, James, Mei, Matthew, Chen, Lu, Song, Joo Y, Bedell, Victoria, Budde, Elizabeth, Armenian, Saro, Puverel, Sandrine, Nikolaenko, Liana, Chen, Robert, Daniels, Shari, Kennedy, Neena, Peters, Lacolle, Rosen, Steven T, Forman, Stephen J, Popplewell, Leslie L, Kwak, Larry W, Herrera, Alex F
Published in Haematologica (Roma) (01.02.2024)
Published in Haematologica (Roma) (01.02.2024)
Get full text
Journal Article
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
Othman, Tamer, Frankel, Paul, Allen, Pamela, Popplewell, Leslie L, Shouse, Geoffrey, Siddiqi, Tanya, Danilov, Alexey V, Ruel, Nora, Daniels, Shari, Peters, Lacolle, Khoo, Stella, Rosen, Steven T, Sharon, Elad, Villalona-Calero, Miguel, Ruel, Christopher, Tuscano, Joseph, Herrera, Alex F
Published in Haematologica (Roma) (18.07.2024)
Published in Haematologica (Roma) (18.07.2024)
Get full text
Journal Article
Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
Herrera, A.F., Palmer, J., Martin, P., Armenian, S., Tsai, N.-C., Kennedy, N., Sahebi, F., Cao, T., Budde, L.E., Mei, M., Siddiqi, T., Popplewell, L., Rosen, S.T., Kwak, L.W., Nademanee, A., Forman, S.J., Chen, R.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
Scuto, A, Krejci, P, Popplewell, L, Wu, J, Wang, Y, Kujawski, M, Kowolik, C, Xin, H, Chen, L, Kretzner, L, Yu, H, Wilcox, W R, Yen, Y, Forman, S, Jove, R
Published in Leukemia (01.03.2011)
Published in Leukemia (01.03.2011)
Get full text
Journal Article
Stability of Citral in Oil-in-Water Emulsions Prepared with Medium-Chain Triacylglycerols and Triacetin
Choi, Seung Jun, Decker, Eric Andrew, Henson, Lulu, Popplewell, L. Michael, McClements, David Julian
Published in Journal of agricultural and food chemistry (09.12.2009)
Published in Journal of agricultural and food chemistry (09.12.2009)
Get full text
Journal Article
Stabilization of orange oil-in-water emulsions: A new role for ester gum as an Ostwald ripening inhibitor
Lim, Sang Soo, Baik, Moo Yeol, Decker, Eric Andrew, Henson, Lulu, Michael Popplewell, L., McClements, David Julian, Choi, Seung Jun
Published in Food chemistry (15.10.2011)
Published in Food chemistry (15.10.2011)
Get full text
Journal Article
Real‐World Early Outcomes of Axicabtagene Ciloleucel for Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Jacobson, C., Hemmer, M. T., Hu, Z., Frank, M., Popplewell, L., Ahmed, N., Lin, Y., Best, T., Beygi, S., Miao, H., Fu, C., Sun, F., Xu, H., Pasquini, M. C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle
Arechavala-Gomeza, V, Graham, I R, Popplewell, L J, Adams, A M, Aartsma-Rus, A, Kinali, M, Morgan, J E, van Deutekom, J C, Wilton, S D, Dickson, G, Muntoni, F
Published in Human gene therapy (01.09.2007)
Published in Human gene therapy (01.09.2007)
Get more information
Journal Article
PHASE I STUDY OF THE CD19/CD3 HALF‐LIFE EXTENDED BITE ® MOLECULE AMG 562 IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA AND FOLLICULAR LYMPHOMA
Mead, M. D., Popplewell, L. L., Subklewe, M., Ghobadi, A., Kuruvilla, J., Kimball, A., Tuglus, C., Agarwal, S., Stieglmaier, J.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL)
Locke, F. L., Lekakis, L., Eradat, H., Munoz, J., Tees, M., Vos, S., Nath, R., Stevens, D., Malik, S., Popplewell, L., Hamadani, M., Oluwole, O., Perales, M., Miklos, D., Fisher, P., Goyal, L., Navale, L., Kaufman, G., Kai, K., Balakumaran, A., Neelapu, S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
A FIRST‐IN‐HUMAN STUDY OF A HALF‐LIFE EXTENDED CD19‐TARGETING BiTE IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, MANTLE CELL LYMPHOMA OR FOLLICULAR LYMPHOMA
Popplewell, L., Verhoef, G., Kuruvilla, J., Tuglus, C., Kischel, R., Stieglmaier, J., Ghobadi, A.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
THE COMBINATION OF VENETOCLAX, LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA INDUCES HIGH RESPONSE RATES AND MRD UNDETECTABILITY
Phillips, T. J., Bond, D., Devata, S., Danilov, A., Herrera, A., Maddocks, K., Wilcox, R., Karimi, Y., Carty, S., Kaminski, M., Popplewell, L.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies
VanderWalde, A M, Sun, C-L, Laddaran, L, Francisco, L, Armenian, S, Berano-Teh, J, Wong, F L, Popplewell, L, Somlo, G, Stein, A S, Nademanee, A, Krishnan, A, Kogut, N, Forman, S J, Bhatia, S
Published in Leukemia (01.05.2013)
Published in Leukemia (01.05.2013)
Get full text
Journal Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA
Shouse, G.P., Xue, T., Herrera, A., Siddiqi, T., Zain, J., Popplewell, L., Forman, S., Budde, E.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL
Schuster, S. J., Dickinson, M., Dreyling, M., Martinez‐Lopez, J., Kolstad, A., Butler, J., Ghosh, M., Popplewell, L., Chavez, J. C., Bachy, E., Kato, K., Harigae, H., Kersten, M. José, Andreadis, C., Riedell, P. A., Abdelhady, A., Zia, A., Morisse, M. C., Fowler, N. H., Thieblemont, C.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
Chen, Robert W, Palmer, Joycelynne M, Tomassetti, Sarah, Popplewell, Leslie L, Alluin, Jessica, Chomchan, Pritsana, Nademanee, Auayporn P, Siddiqi, Tanya, Tsai, Ni-Chun, Chen, Lu, Zuo, Fay, Abary, Rosemarie, Cai, Ji-Lian, Herrera, Alex F, Rossi, John J, Rosen, Steven T, Forman, Stephen J, Kwak, Larry W, Holmberg, Leona A
Published in Journal of hematology and oncology (28.06.2018)
Published in Journal of hematology and oncology (28.06.2018)
Get full text
Journal Article